Onsdag 12 Mars | 16:50:52 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2025-10-30 07:30 Kvartalsrapport 2025-Q3
2025-07-10 07:30 Kvartalsrapport 2025-Q2
2025-06-26 N/A Årsstämma
2025-05-23 N/A X-dag ordinarie utdelning QLINEA 0.00 SEK
2025-04-29 07:30 Kvartalsrapport 2025-Q1
2025-04-03 N/A Extra Bolagsstämma 2025
2025-02-28 - Bokslutskommuniké 2024
2024-11-05 - Kvartalsrapport 2024-Q3
2024-07-11 - Kvartalsrapport 2024-Q2
2024-06-28 - Årsstämma
2024-06-12 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2024-05-31 - Kvartalsrapport 2024-Q1
2024-02-27 - Bokslutskommuniké 2023
2023-11-02 - Kvartalsrapport 2023-Q3
2023-07-13 - Kvartalsrapport 2023-Q2
2023-07-03 - Extra Bolagsstämma 2023
2023-06-13 - Årsstämma
2023-05-24 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-05-25 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2022-05-24 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-05-26 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2021-05-25 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-07-16 - Kvartalsrapport 2020-Q2
2020-05-27 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2020-05-26 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-02-13 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-07-18 - Kvartalsrapport 2019-Q2
2019-05-23 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2019-05-22 - Årsstämma
2019-05-03 - Kvartalsrapport 2019-Q1
2019-02-14 - Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Q-Linea är verksamt inom medicinteknik. Bolaget är specialiserat inom forskning och utveckling av instrument och förbrukningsartiklar. Produkterna används huvudsakligen vid behandling av infektionssjukdomar och blodförgiftning, och innefattar diagnostik- och analysverktyg, samt grundläggande provhantering. Tekniken baseras på den så kallade ID- samt AST tekniken. Q-Linea grundades 2008 och har huvudkontor i Uppsala.
2025-02-11 11:00:00

Q-linea AB (publ) (OMX: QLINEA) today shared updates on the progress of the introduction of ASTar® System in the GCC region.

During the first week of February, ASTar instrument was on display in the booth of the AMICO Group at Medlab Middle East in Dubai, United Arab Emirates. With over 28,000 visitors and close to 900 exhibiting companies in 2024, it is the premier event for introducing new technologies for medical laboratories in Asia, Africa and the GCC region. Supported by colleagues from Q-linea, the AMICO team performed multiple demos to representatives from private and public hospitals, and ASTar was very well received.

As a continuation of the business development strategy in the Region, AMICO will host a Sepsis Management Day on February 19 in Riyadh, Saudi Arabia. The roll-out plan combines educating healthcare professionals about the benefits of rapid AST and its role in patient care with product evaluations at select hospitals.

“We are very pleased with the reception of ASTar at Medlab and impressed with AMICO’s professionalism in navigating the multi-jurisdictional region quickly and effectively which is already resulting in concrete customer conversations,” said Franco Pellegrini, VP Sales EMEA at Q-linea.

Sherif Harydi, Business Development Director at AMICO Group, said: ” We are very pleased by the reception ASTar System has received in the market so far. We look forward to working together with the Q-linea team to introduce ASTar in our region through events and product evaluations.”

Previous communication, Sept 27, 2024: https://qlinea.com/mfn_news/q-linea-enters-the-middle-east-region-through-partnership-with-amico-group/?ln=en